BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/24/2017 10:31:00 AM | Browse: 1230 | Download: 1152
Publication Name World Journal of Methodology
Manuscript ID 30770
Country/Territory Cyprus
Received
2016-10-19 10:39
Peer-Review Started
2016-10-19 16:14
To Make the First Decision
2016-11-30 08:54
Return for Revision
2016-11-30 14:19
Revised
2016-12-15 00:00
Second Decision
2016-12-20 15:49
Accepted by Journal Editor-in-Chief
2016-12-21 01:00
Accepted by Company Editor-in-Chief
2017-01-03 15:24
Articles in Press
2017-01-03 15:24
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-03-20 09:11
Publish the Manuscript Online
2017-03-24 10:35
ISSN 2222-0682 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Chromogranin A as a valid marker in oncology: Clinical application or false hopes?
Manuscript Source Invited Manuscript
All Author List Stavros Gkolfinopoulos, Konstantinos Tsapakidis, Konstantinos Papadimitriou, Demetris Papamichael and Panteleimon Kountourakis
Funding Agency and Grant Number
Corresponding Author Panteleimon Kountourakis, MD, PhD, Department of Medical Oncology, BOC Oncology Center, 32 Acropoleos Ave, 2006 Strovolos, Nicosia, Cyprus. pantkount@gmail.com
Key Words Cancer; Neuroendocrine tumors; Prognosis; Chromogranin A; Biomarker
Core Tip In the era of targeted therapy, there is an unmet need for the development of more sensitive, specific and reliable biomarkers for early diagnosis, prognosis and detection of early recurrence to tumors which comprise an extremely heterogeneous group.
Publish Date 2017-03-24 10:35
Citation Gkolfinopoulos S, Tsapakidis K, Papadimitriou K, Papamichael D, Kountourakis P. Chromogranin A as a valid marker in oncology: Clinical application or false hopes? World J Methodol 2017; 7(1): 9-15
URL http://www.wjgnet.com/2222-0682/full/v7/i1/9.htm
DOI http://dx.doi.org/10.5662/wjm.v7.i1.9
Full Article (PDF) WJM-7-9.pdf
Full Article (Word) WJM-7-9.doc
Manuscript File 30770-Review.docx
Answering Reviewers 30770-Answering reviewers.pdf
Audio Core Tip 30770-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 30770-Conflict-of-interest statement.pdf
Copyright License Agreement 30770-Copyright assignment.pdf
Peer-review Report 30770-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 30770-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 30770-Scientific misconduct check.pdf
Scientific Editor Work List 30770-Scientific editor work list.pdf